Nodal metastases and lymphadenectomy in differentiated thyroid carcinoma;Differenziertes Schilddrüsenkarzinom: Zur Chirurgie und Bedeutung von Lymphknotenbefall

Chirurg

Volumn 73, Issue 1, 2002, Pages 38-45

  Gemsenjager E ^a   Heitz, P U ^b   Martina, B ^c   Schweizer, I ^a  

^a Chirurgische Klinik Stadtspital Waid   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c KANTONSSPITAL BASEL   (Switzerland)

Author keywords

Follicular thyroid carcinoma; Nodal metastases; Papillary thyroid carcinoma; Prophylactic lymphadenectomy; Selective treatment; Therapeutic lymphadenectomy

Indexed keywords

RADIOACTIVE IODINE;

ADENOCARCINOMA; ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MIDDLE AGED; MORTALITY; PAPILLARY CARCINOMA; PATIENT SELECTION; PROGNOSIS; RISK FACTOR; SURVIVAL; THYROID TUMOR; THYROIDECTOMY; TIME; TUMOR RECURRENCE;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS;

EID: 18344404188     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s104-002-8026-3     Document Type: Article

References (31)

1. Attie JN, Khafif RA, Steckler RM (1971) Elective neck dissection in papillary carinoma of the thyroid. Am J Surg 122:464
2. Buhr HJ, Mann B (1999) Thyreoidektomie und Lymphadenektomie. Chirurg 70:987
3. Cady B (1998) Beyond risk-groups - a new look at differentiated thyroid cancer. Surgery 124:947
4. Clark OH (1996) Predictors of thyroid tumor aggressiveness. West J Med 165:131
5. Clark OH (1999) Invited commentary. World J Surg 23:973
6. DeGroot LJ, Kaplan EL, Shukla MS, Salti G, Straus FH (1995) Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 80:2946
7. DeGroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:441
8. Dixon E, McKinnon JG, Pasieka JL (2000) Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thryoid neoplasms. World J Surg 24:1396-1401
9. Dralle H, Gimm O (1996) Lymphadenektomie beim Schilddrüsencarcinom. Chirurg 67:788
10. Gemsenjäger E, Heitz PU, Martina B (1997) Selective treatment of differentiated thyroid carcinoma. World J Surg 21:546
11. Gemsenjäger E, Heitz PU, Seifert B, Martina B, Schweizer I (2001) Differentiated thyroid carcinoma. Swiss Med Wkly 131:157
12. Gilliand FD, Hunt WC, Morris DM, Key CR (1997) Prognostic factors for thyroid carcinoma. Cancer 79:564
13. Grebe SKG, Hay ID (1997) Follicular cell-derived thyroid carcinomas. In: Endocrine Neoplasms. A.Arnold editor. Cancer Treat Res 89:91
14. Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545
15. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, Van Heerden JA, Goellner JR (1998) Unilateral total lobectomy. Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 124:958
16. Hermanek P (1996) Will-Rogers-Phänomen - Fakt oder Fiktion? Chirurg 67:769
17. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985-1995. Cancer 83:2638
18. Kelemen PR, Van Herle AJ, Giuliano AE (1998) Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 133:288-292
19. McHerny C, Jarosz H, Davis M, Barbato AL, Lawrence AM, Paloyan E (1989) Selective postoperative radioactive iodine treatment of thyroid carcinoma. Surgery 106:956-1009
20. McHenry C, Rosen IB (1991) Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 162:353
21. Moley JF (1995) Medullary thyroid cancer. Surg Clin North Am 75:405-420
22. Noguchi M, Katev N, Miwa K (1998) Therapeutic strategies and long-term results in differentiated thyroid cancer. J Surg Oncol 67:52
23. Pasieka JL, Rotstein LE (1993) Consensus conference on well-differentiated thyroid cancer: a summery. Can J Surg 36:298
24. Röher HD (1994) Kommentar. Chirurg 65:1098
25. Salvesen H, Njolstad PR, Akslen LA, Albrektsen G, Soreide O, Varhaug JE (1992) Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg 158:583
26. Scheumann GFW, Gimm O, Wegener G, Hundshagen H, Dralle H (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18:559
27. Shaha AR, Shah JP, Loree TR (1997) Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol 4:328
28. Singer PA, Cooper DS, Daniels GH et al. (1996) Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med 156:2165-2172
29. Tisell LE, Nilsson B, Mölne J, Hansson G, Fjälling M, Jansson S, Wingren U (1996) Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 20:854
30. UICC (1992) International Union Against Cancer: TNM Klassifikation maligner Tumoren. 4. Aufl. Springer, Berlin Heidelberg New York Tokyo
31. Woolner LB (1971) Thyroid carcinoma: pathologic classification with data on prognosis. Sem Nucl Med 1:481-502